表紙:外側上顆炎治療市場規模、シェア、成長分析、治療タイプ別、エンドユーザー別、地域別 - 産業予測、2025年~2032年
市場調査レポート
商品コード
1789241

外側上顆炎治療市場規模、シェア、成長分析、治療タイプ別、エンドユーザー別、地域別 - 産業予測、2025年~2032年

Lateral Epicondylitis Treatment Market Size, Share, and Growth Analysis, By Treatment Type (Non-Surgical Treatments, Surgical Treatments), By End User (Hospitals, Specialty Clinics), By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 172 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
外側上顆炎治療市場規模、シェア、成長分析、治療タイプ別、エンドユーザー別、地域別 - 産業予測、2025年~2032年
出版日: 2025年08月07日
発行: SkyQuest
ページ情報: 英文 172 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

外側上顆炎治療の世界市場規模は、2023年に12億米ドルと評価され、2024年の12億5,000万米ドルから2032年には17億4,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは4.2%で成長する見通しです。

外側上顆炎治療の世界市場は、特にアスリート、肉体労働者、オフィスワーカーなど、反復性疲労損傷に罹患する人の増加によって大きな成長を遂げています。PRP注射や衝撃波治療などの低侵襲治療オプションが利用可能になりつつあることに加え、予防対策に対する意識が高まっていることが、治療へのアクセスを高めています。さらに、外来手術センターの普及と相まって、再生医療の進歩が患者の選択肢を広げています。高齢者人口の拡大や早期介入の重要性に対する認識の高まりは、市場の拡大にさらに貢献しており、世界的に外側上顆炎治療ソリューションのための強固な状況を作り出しています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • ケーススタディ
  • 顧客購買行動分析

外側上顆炎治療市場規模:治療タイプ別& CAGR(2025-2032)

  • 市場概要
  • 非外科的治療
    • 医薬品
    • 理学療法
    • 矯正器具とブレース
    • その他の非外科的治療
  • 外科的治療
    • 関節鏡手術
    • 開腹手術
    • その他の外科的治療

外側上顆炎治療市場規模:年齢層別& CAGR(2025-2032)

  • 市場概要
  • 小児
  • 成人
  • 高齢者

外側上顆炎治療市場規模:エンドユーザー別& CAGR(2025-2032)

  • 市場概要
  • 病院
  • 専門クリニック
  • 外来手術センター
  • 在宅ケア設定

外側上顆炎治療市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024年)

主要企業プロファイル

  • Teikoku Pharma, Inc.
  • Kasiak Research Pvt. Ltd.
  • Molecular Pharmacology Limited
  • Chugai Pharmaceutical Co., Ltd.
  • Seikagaku Corporation
  • OMRON Corporation
  • BioMedical Life Systems, Inc.
  • Zynex, Inc.
  • EMS Physio Ltd.
  • DJO Global, Inc.
  • Beurer GmbH
  • 3M
  • AKSIGEN
  • BTL Corporate

結論と提言

目次
Product Code: SQMIG45N2126

Global Lateral Epicondylitis Treatment Market size was valued at USD 1.2 billion in 2023 and is poised to grow from USD 1.25 billion in 2024 to USD 1.74 billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).

The global market for lateral epicondylitis treatment is experiencing significant growth driven by a rise in individuals affected by repetitive strain injuries, particularly among athletes, manual laborers, and office workers. The increasing availability of minimally invasive treatment options, such as PRP injections and shockwave therapy, along with heightened awareness of preventive measures, is enhancing treatment accessibility. Furthermore, advancements in regenerative medicine, coupled with the proliferation of ambulatory surgical centers, are broadening the options available for patients. The expanding elderly population and an increasing recognition of the importance of early intervention further contribute to the market's expansion, creating a robust landscape for lateral epicondylitis treatment solutions worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lateral Epicondylitis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lateral Epicondylitis Treatment Market Segments Analysis

Global Lateral Epicondylitis Treatment Market is segmented by Treatment Type, End User and region. Based on Treatment Type, the market is segmented into Non-Surgical Treatments and Surgical Treatments. Based on End User, the market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgical Centres and Homecare Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lateral Epicondylitis Treatment Market

The rising prevalence of lateral epicondylitis among various groups, including athletes, manual laborers, and office employees, significantly fuels the demand in the treatment market. This surge is largely attributed to the rise in repetitive motion activities across different occupations. Consequently, there is a heightened need for both non-surgical treatments, such as braces and physiotherapy, as well as surgical options like arthroscopic release. This trend is particularly pronounced in developed areas with aging populations who actively seek effective solutions for managing this condition. Overall, the broader awareness and recognition of lateral epicondylitis drive the market's growth trajectory.

Restraints in the Global Lateral Epicondylitis Treatment Market

Despite the efficacy of biologic treatments such as platelet-rich plasma and stem cell therapies, as well as shockwave therapy, their high costs combined with inconsistent insurance coverage-particularly in less developed regions-pose significant challenges. This financial hurdle restricts their widespread use and encourages healthcare providers and patients to turn to more affordable non-biologic options, such as corticosteroids. As a result, the market for Lateral Epicondylitis treatment is impacted, with a tendency to favor less expensive alternatives that may not offer the same long-term benefits, thus hindering the adoption of advanced therapeutic methods.

Market Trends of the Global Lateral Epicondylitis Treatment Market

The Global Lateral Epicondylitis Treatment market is witnessing a significant shift toward regenerative medicine, particularly with the increasing adoption of biologic therapies such as platelet-rich plasma therapy, stem cell injections, and growth factor-based treatments. These innovative therapies are gaining traction due to their potential to enhance natural tissue repair and reduce recurrence rates, appealing to both healthcare providers and patients seeking effective long-term solutions. This trend is especially pronounced in North America and Europe, where healthcare systems are increasingly supportive of these advanced treatment modalities, indicating a broader acceptance of biologics within traditional healthcare frameworks and driving market growth.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Customer Buying Behavior Analysis

Global Lateral Epicondylitis Treatment Market Size by Treatment Type & CAGR (2025-2032)

  • Market Overview
  • Non-Surgical Treatments
    • Medications
    • Physical therapy
    • Orthotics and braces
    • Other non-surgical treatments
  • Surgical Treatments
    • Arthroscopic surgery
    • Open surgery
    • Other surgical treatments

Global Lateral Epicondylitis Treatment Market Size by Age Group & CAGR (2025-2032)

  • Market Overview
  • Pediatric
  • Adult
  • Geriatric

Global Lateral Epicondylitis Treatment Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centres
  • Homecare Settings

Global Lateral Epicondylitis Treatment Market Size & CAGR (2025-2032)

  • North America (Treatment Type, Age Group, End User)
    • US
    • Canada
  • Europe (Treatment Type, Age Group, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Treatment Type, Age Group, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Treatment Type, Age Group, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Treatment Type, Age Group, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Teikoku Pharma, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kasiak Research Pvt. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molecular Pharmacology Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Chugai Pharmaceutical Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Seikagaku Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OMRON Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioMedical Life Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zynex, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EMS Physio Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DJO Global, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beurer GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3M
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AKSIGEN
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BTL Corporate
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations